A new family of very promising silver-based anti-cancer drugs has been discovered by researchers in South Africa. The most promising silver thiocyanate phosphine complex among these, called UJ3 for short, has been successfully tested in rats and in human cancer cells in the laboratory. According to Professor Marianne Cronjé, Head of the Department of Biochemistry at the University of Johannesburg, the UJ3 complex is as effective as the industry-standard drug Cisplatin in killing cancer cells in laboratory tests done on human breast cancer and melanoma, a very dangerous form of skin cancer, as well.
Guest (studio): Professor Marianne Cronjé, Head of the Department of Biochemistry at the University of Johannesburg